Over $4 Million Raised for Cystic Fibrosis
Over $4 Million Raised for Cystic Fibrosis
CARSTAR, North America’s leading provider of premier collision repairs, is celebrating a North American milestone of raising over $4 million for cystic fibrosis research, care and advocacy.
“Our franchise family works tremendously hard to host events that raise valuable funds and awareness in their respective communities for cystic fibrosis,” says Dean Fisher, president, CARSTAR. “It is directly because of them and the additional support of our vendor, insurance and corporate partners that we are able to enjoy this milestone moment together.”
CARSTAR began fundraising for cystic fibrosis (CF) in Canada over 20 years ago, when a franchise partner’s granddaughter received a cystic fibrosis diagnosis. Since then, the CARSTAR commitment to its charity of choice has only accelerated, as have the funds raised. Whether it is hosting a car wash, golf tournament, participating in a charity walk, holding a garage sale or providing a simple donation – every initiative large and small has helped this North American leader raise $4 million for its cystic fibrosis partners.
“CARSTAR and its partners are a shining example of the impact that can be made through corporate philanthropy,” said Kelly Grover, President and CEO, Cystic Fibrosis Canada. “The funds raised by CARSTAR will help people living with cystic fibrosis live longer, healthier lives. Thank you for your generosity.”
Cystic fibrosis is a fatal genetic disease with no cure. CF causes various effects on the body, but mainly affects the digestive system and lungs. A defective gene causes a thick, buildup of mucus in the lungs, pancreas, and other organs leading to infections, extensive lung damage, and eventually, respiratory failure.
Dean Fisher continued, “It is moments like these where I am reminded just how wonderful our CARSTAR family is, and makes me even more grateful to be a part of it. We are committed to supporting this cause and hope to one day soon be celebrating the milestone of a cure being found for cystic fibrosis.”